Jeffrey Sunman, Ph.D., is involved in patent drafting and patent prosecution in the areas of biotechnology, pharmacology, and life sciences. Dr. Sunman received his B.S. in biology from Stetson University and his Ph.D. in pharmaceutical sciences from Mercer University. Dr. Sunman completed postdoctoral fellowships at the University of North Carolina at Chapel Hill and the National Institute of Environmental Health Sciences.
Dr. Sunman’s research focused on aspects of pharmacology, drug metabolism, and cancer biology. During his graduate studies, he characterized novel inhibitors of peptide amidation in models of inflammation and tumorigenesis. At UNC-CH, he studied changes in hepatic enzyme activity in hepatitis C virus-infected liver and the role of arachidonic acid-metabolizing cytochrome P450 enzymes in the survival of primary hepatocytes. At NIEHS, Dr. Sunman utilized lentivirus-based protein expression techniques and structure-function analyses to identify novel mechanisms by which proteases in the tumor microenvironment induce integrin-dependent cell migration during metastasis.
His academic research experience encompassed the fields of molecular and cellular biology, pharmacology, immunology, cancer biology, and drug metabolism, leading to co-authored publications in peer-reviewed journals including the Journal of Pharmacology and Experimental Therapeutics, Drug Metabolism and Disposition, Molecular Carcinogenesis, Biochemistry and Cell Biology, Developmental Biology, and Cell Biology and Toxicology.
- Experienced in the preparation and prosecution of U.S. and foreign patent applications in the areas of biotechnology, pharmacology, immunology, and general life sciences. Expertise includes transgenic plants and organisms, recombinant DNA technology, monoclonal and humanized antibodies, pharmaceutical compositions and formulations, and methods of disease treatment.